Tech Company Financing Transactions
Nucleai Funding Round
On 4/3/2024, Nucleai landed $14 million in investment from M Ventures and private investors.
Transaction Overview
Company Name
Announced On
4/3/2024
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Undisclosed
Investors
M Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the deployment of its spatial analysis technology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1375 W Fulton Ave. 650
Chicago, IL 60607
USA
Chicago, IL 60607
USA
Phone
Undisclosed
Website
Email Address
Overview
We are transforming precision medicine with AI-powered pathology. Our team's work is a unique collaboration of experienced AI technologists, physicians and exceptional healthcare research professionals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Avi Veidman
Chief Medical Officer
Ori Zelichov
Chief Operating Officer
Eliron Amir
Chief Technical Officer
Albert Achtenberg
VP - R & D
Lotan Chorev
VP - Sales
Jonathan Daniels
Browse more venture capital transactions:
Prev: 4/3/2024: Netgain venture capital transaction
Next: 4/3/2024: Aitrics venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC transactions reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs